Global Microarray Industry
New Study On “2019-2023 Microarray Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
The testing and research of a large number of genes cannot be achieved by using traditional methods. Hence, the microarray is one of the technologies that are used by researchers to overcome the limitation of traditional tools. Using microarrays, the researchers can analyze the expression of many genes simultaneously and efficiently. Microarrays are used in various application such as gene discovery, diseases diagnosis, drug discovery, toxicological research and so on. The widespread global adoption of personalized medication and the need for the error-free molecular testing tool are the factor that is boosting the growth of the microarray market globally. The increasing prevalence of chronic diseases leads to the demand for an innovative molecular testing solution to perform the microbiology, cancer, and pharmacogenetic testing. Moreover, the usage of microarrays in bacterial pathogenesis research is also fuelling the microarray market growth.
Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3739592-global-microarray-market-research-and-forecast-2018-2023
Although, the lack of funding for microarray development and the cost of preparing microarrays are the major restraining factor for this market. The availability of some microarrays such as Glycan is under threat due to the difficulty in procuring and distribution which can hinder the growth of the microarray market. Whereas, the emerging technologies for the diagnosis of microbial infections and the need for detection of chromosomal alteration also increase the demand for microarrays. Additionally, the increasing focus towards the function and recognition of glycan can be a huge opportunity for this market.
Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is dominating the global microarray market. The growth is attributed to the increasing prevalence of chronic diseases and extensive proteomics and genomics research. Europe is the second largest market due to the technological advancement in the biotechnology field. Asia-Pacific is considered as the growing market during the forecast period. The growing need for the molecular testing solution and high penetration of new technology are the key factors for the growth of the microarray market in Asia-Pacific region.
There are various companies involved in the microarray technology such as Abcam PLC, Agilent Technologies Inc., Applied Microarrays, Inc., CDI Laboratories, Inc., GE Healthcare, PerkinElmer, Inc., RayBiotech, Inc. And so on. The companies are focused on developing advanced microarray solutions to stay competitive in the market. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players.
The market study of the global microarrays market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include
• Financial reports of companies involved in the market
• Authentic Public Databases such as the OICA, OECD, WHO, and others
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog.
The report is intended for genomics and proteomics companies, research organizations, biotechnology companies, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
Global microarray market is segmented on the basis of regional outlook and following segments:
1. Global Microarray Market Research and Analysis by Type
2. Global Microarray Market Research and Analysis by Application
3. Global Microarray Market Research and Analysis by Geography
The report covers
• Comprehensive research methodology of the global microarray market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global microarray market.
• Insights about market determinants which are stimulating the global microarray market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.
1. Abcam PLC
2. Agilent Technologies, Inc.
3. Applied Microarrays, Inc.
4. Arrayit Corp.
5. Aurora Biomed Inc.
6. Axela, Inc.
7. AXO Science
8. AyoxxA Biosystems GmbH
10. bioMérieux SA
11. Bio-Rad Laboratories, Inc.
12. CDI Laboratories, Inc.
13. Cepheid, Inc.
14. F. Hoffmann-La Roche AG
15. Fluidigm Corp.
16. GE Healthcare
17. IHC World, LLC.
18. Illumina, Inc.
19. Indevr, Inc.
20. Luminex Corp.
21. Merck KGaA
22. Meso Scale Diagnostics, LLC.
23. Origene Technologies, Inc
24. Pantomics, Inc.
25. Partek, Inc.
26. PerkinElmer, Inc.
28. Qiagen N.V.
29. RayBiotech, Inc.
30. SQI Diagnostics Inc.
31. Takara Bio, Inc.
32. Thermo Fisher Scientific, Inc.
33. US Biomax, Inc.
34. US Bioupton International, LLC
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3739592-global-microarray-market-research-and-forecast-2018-2023
Some Major Points from Table of content:
- Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
3. Market Determinants
3.1.1. Need for Error Free Molecular Testing Tool
3.1.2. Increasing Prevalence of Chronic Diseases
3.1.3. Rising Focus Towards Drug Discovery
3.1.4. Increasing Usage of Microarrays in Bacterial Pathogenesis Research
3.2.1. Lack of Research Funding
3.2.2. Cost of Microarrays
3.3.1. Growth in Investment for Genomic and Proteomic Research
3.3.2. Increasing Adoption of Personalized Medication
For more information or any query mail at email@example.com
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349